Arkolith/Insider Trading/CLDI/Form 4

Camaisa Allan

DirectorCalidi Biotherapeutics, Inc. (CLDI) · full profile →Form 4 · filed Dec 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Sell(S)850$1.46$1K77K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-028030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML